Dorsey Wright & Associates - CATABASIS PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

CATABASIS PHARMACEUTICALS IN's ticker is and the CUSIP is 14875P206. A total of 64 filers reported holding CATABASIS PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
Dorsey Wright & Associates ownership history of CATABASIS PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2020$7,000
-22.2%
1,060
-25.0%
0.00%
-50.0%
Q2 2020$9,000–1,414–0.00%–
 Download
Other shareholders

There were no reported owners of CATABASIS PHARMACEUTICALS IN in Q4 2020.

NameSharesValueWeighting ↓
View complete list of CATABASIS PHARMACEUTICALS IN shareholders